Aerie Pharmaceuticals Inc... (AERI)
NASDAQ: AERI
· Real-Time Price · USD
15.25
0.00 (0.00%)
At close: Nov 18, 2022, 10:00 PM
Aerie Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|
| License Revenue | 82M | 83.14M | 69.89M | 24.18M |
| License Revenue Growth | -1.37% | +18.96% | +189.02% | n/a |
| Product Revenue | 112.13M | n/a | n/a | n/a |
| Product Revenue Growth | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 33.88M | 28.15M | 31.52M | 36.01M | 34.66M | 34.54M | 32.6M | 35.02M | 32.03M | 33.24M | 36.9M | 35.47M | 32.17M | 34.48M | 36.28M | 12.97M | 39.93M | 39.89M | 27.82M | 22.21M | 19.77M | 17.15M | 14.47M | 14.66M | 10.63M | 9.39M | 9.8M | 7.65M | 7.46M | 7.5M | 8.02M |
| Selling, General, and Administrative Revenue Growth | +20.35% | -10.71% | -12.46% | +3.90% | +0.33% | +5.96% | -6.91% | +9.33% | -3.63% | -9.93% | +4.05% | +10.25% | -6.70% | -4.96% | +179.80% | -67.53% | +0.11% | +43.37% | +25.26% | +12.33% | +15.28% | +18.50% | -1.29% | +37.99% | +13.22% | -4.23% | +28.15% | +2.49% | -0.53% | -6.49% | n/a |
| Research and Development Revenue | 21.99M | 19.56M | 25.17M | 20.85M | 19.13M | 17.97M | 17.89M | 18.73M | 16.16M | 19.94M | 19.17M | 30.79M | 21.8M | 20.9M | 17.88M | 26.49M | 28.5M | 18.16M | 12.97M | 38.1M | 12.41M | 10.62M | 10.95M | 14.09M | 12.69M | 13.3M | 12.31M | 12.3M | 9.9M | 10.63M | 11.62M |
| Research and Development Revenue Growth | +12.46% | -22.31% | +20.76% | +8.96% | +6.48% | +0.42% | -4.46% | +15.84% | -18.94% | +4.02% | -37.74% | +41.28% | +4.27% | +16.89% | -32.49% | -7.05% | +56.98% | +39.97% | -65.95% | +207.07% | +16.89% | -3.09% | -22.27% | +11.07% | -4.63% | +8.08% | +0.06% | +24.21% | -6.80% | -8.53% | n/a |